Hot Papers

T.D. Halazonetis, K. Georgopoulos, M.E. Greenberg, P. Leder, "c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities," Cell, 55, 917-24, 2 December 1988. Thanos Halazonetis (Harvard Medical School, Boston): "A number of cancer-causing genes (oncogenes) have been shown to code for factors regulating gene expression. The protein products of two such oncogenes, c-jun and c-fos, had been shown to be part of a protein complex that regulates the transcripti

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

T.D. Halazonetis, K. Georgopoulos, M.E. Greenberg, P. Leder, "c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities," Cell, 55, 917-24, 2 December 1988.

Thanos Halazonetis (Harvard Medical School, Boston): "A number of cancer-causing genes (oncogenes) have been shown to code for factors regulating gene expression. The protein products of two such oncogenes, c-jun and c-fos, had been shown to be part of a protein complex that regulates the transcription of genes associated with cell division and differentiation. In this paper, we describe how the interaction of the Jun and Fos proteins modulates their DNA-binding activity. When the Jun and Fos proteins are cotranslated, they form a heterodimer of high specific DNA-binding activity. The two proteins have homologous domains that mediate heterodimer formation and subsequent DNA binding. The domain of the Jun protein, in addition to interacting with the homologous domain of the Fos protein, can ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies